Back
Escalade, Inc. 10K Form
Sell
40
ESCA
Escalade, Inc.
Last Price:
$12.67
Seasonality Move:
2.6%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-25 | 10Q | ESCA/Escalade, Inc. Quarterly |
| 2024-03-29 | 10Q | ESCA/Escalade, Inc. Quarterly |
| 2023-10-26 | 10Q | ESCA/Escalade, Inc. Quarterly |
| 2023-07-27 | 10Q | ESCA/Escalade, Inc. Quarterly |
| 2023-05-09 | 10Q | ESCA/Escalade, Inc. Quarterly |
| 2022-10-27 | 10Q | ESCA/Escalade, Inc. Quarterly |
Receive ESCA News And Ratings
See the #1 stock for the next 7 days that we like better than ESCA
ESCA Financial Statistics
Sales & Book Value
| Annual Sales: | $251.5M |
|---|---|
| Cash Flow: | $-1.3M |
| Price / Cash Flow: | 6.65 |
| Annual Sales: | $12.48 |
| Price / Book: | 1.01 |
Profitability
| EPS (TTM): | 0.91030 |
|---|---|
| Net Income (TTM): | $12.7M |
| Gross Margin: | $59.4M |
| Return on Equity: | 7.48% |
| Return on Assets: | 5.53% |
Escalade, Inc. Earnings Forecast
Key Escalade, Inc. Financial Ratios
-
The Gross Profit Margin over the past 41 years for ESCA is 23.62%.
-
The Selling, General & Administrative Expenses for ESCA have been equal to 17.22% of Gross Profit Margin.
-
The Research & Development expenses have been 1.27% of Revenue.
-
The Interest Expense is 17.73% of Operating Income.
-
The Net Earning history of ESCA is 5.16% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 23 years.
Escalade, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Leisure Products |
| Sector: | Consumer Discretionary |
| Current Symbol: | ESCA |
| CUSIP: | 296056 |
| Website: | escaladeinc.com |
Debt
| Debt-to-Equity Ratio: | 0.13 |
|---|---|
| Current Ratio: | 3.3 |
| Quick Ratio: | 1.34 |
Price-to-Earnings
| Trailing P/E Ratio: | 13.68 |
|---|---|
| Forward P/E Ratio: | 0 |
ESCA Technical Analysis vs Fundamental Analysis
Sell
40
Escalade, Inc. (ESCA)
is a Sell
Is Escalade, Inc. a Buy or a Sell?
-
Escalade, Inc. stock is rated a SellThe current Escalade, Inc. [ESCA] share price is $12.65. The Score for ESCA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.